60 Degrees Pharmaceuticals, LLC (NASDAQ: SXTP), Washington, DC – FDA Inspections
Inspection records and compliance data for 60 Degrees Pharmaceuticals, LLC in Washington, District of Columbia. 1 FDA inspection on record, last inspected June 08, 2018. Publicly traded as NASDAQ: SXTP.
This profile covers 60 Degrees Pharmaceuticals, LLC based in Washington, District of Columbia, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 8, 2018.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 8, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1056636 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
60 Degrees Pharmaceuticals, LLC
Stock ticker
SXTP
Exchange
NASDAQ
Share price
$0.53
Market cap
$1.9M
Price as of
November 13, 2026
FEI Number
3014281348
Address
1025 Connecticut Ave Nw, Washington, District of Columbia 20036, United States
Country
United States
ID: 35d6af88-66c6-497f-b49f-75dc83b93eec